Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Medical Devices
Overview
Conditions
Intellectual Property
Research
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Email:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Intellectual Property

Nutra Pharma owns 11 patents for the test kit technology. These patents provide for the protection and exclusive use of the paraffin-baiting system and detection systems.

Patents

Patent Number: 5,153,119
METHOD FOR SPECIATING AND IDENTIFYING MAI (MYCOBACTERIUM AVIUM-INTRACELLULARE)
 
 
Patent Number: 5,316,918
METHOD AND APPARATUS FOR TESTING MAI (MYCOBACTERIUM AVIUM-INTRACELLULARE) FOR ANTIMICROBIAL AGENT SENSITIVITY
 
 
Patent Number: 5,472,877
APPARATUS FOR DETERMINING THE PRESENCE OR ABSENCE OF MAI (MYCOBACTERIUM AVIUM-INTRACELLULARS)
 
 
Patent Number: 5,569,592
APPARATUS FOR TESTING MAI (MYCOBACTERIUM AVIUM-INTRACELLULARE) FOR ANTIMICROBIAL AGENT SENSITIVITY
 
 
Patent Number: 5,776,722
METHOD OF TESTING A BODY SPECIMEN TAKEN FROM A PATIENT FOR THE PRESENCE OR ABSENCE OF A MICROORGANISM A FURTHER ASSOCIATED METHOD AND ASSOCIATED APPARATUS
 
 
Patent Number: 5,846,760
METHOD FOR DETERMINING A PRESENCE OR ABSENCE OF A NONPARAFFINOPHILIC HYDROPHOBIC MICROORGANISM IN A BODY SPECIMEN AND AN ASSOCIATED APPARATUS
 
 
Patent Number: 5,854,014
APPARATUS FOR TESTING PARAFFINOPHILIC MICROORGANISMS FOR ANTIMICROBIAL SENSITIVITY
 
 
Patent Number: 5,882,920
APPARATUS FOR DETERMINING THE PRESENCE OR ABSENCE OF A NONPARAFFINOPHILIC MICROORGANISM
 
 
Patent Number: 5,935,806
METHOD AND APPARATUS FOR SPECIATING AND IDENTIFYING MAI (MYCOBACTERIUM AVIUM-INTRACELLULARE) AND TESTING THE SAME FOR ANTIBIOTIC SENSITIVITY
 
 
Patent Number: 5,981,210
METHOD FOR DETERMINING A PRESENCE OR ABSENCE OF A NONPARAFFINOPHILIC HYDROPHOBIC MICROORGANISM IN A BODY SPECIMEN BY USING A DNA EXTRACTION PROCEDURE AND A NOVEL DNA EXTRACTION PROCEDURE
 
 
Patent Number: 5,989,902
METHOD OF DETERMINING THE ANTIMICROBIAL AGENT SENSITIVITY OF A NONPARAFFINOPHILIC HYDROPHOBIC MICROORGANISM AND AN ASSOCIATED APPARATUS
 
Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.
 

 

 
Recent News
 
July 24, 2014
Nutra Pharma Announces Infrastructure Improvements to Handle Increased Sales


June 10, 2014
Nutra Pharma Announces Contracts for Nyloxin Television Commercials


January 07, 2014
Nutra Pharma Announces the First Shipments and Product Delivery to MyNyloxin.com Independent Entrepreneurs


 
 
Announcements
Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
 
 
Facebook   Twitter
 
NPC
Privacy Policy Code of Ethics